416 related articles for article (PubMed ID: 9696789)
41. Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1.
Biswas S; Smith C; Field HJ
J Antimicrob Chemother; 2007 Aug; 60(2):274-9. PubMed ID: 17550887
[TBL] [Abstract][Full Text] [Related]
42. Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures.
Liptak LM; Uprichard SL; Knipe DM
J Virol; 1996 Mar; 70(3):1759-67. PubMed ID: 8627698
[TBL] [Abstract][Full Text] [Related]
43. Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication.
Slanina H; Weger S; Stow ND; Kuhrs A; Heilbronn R
J Virol; 2006 Jun; 80(11):5241-50. PubMed ID: 16699004
[TBL] [Abstract][Full Text] [Related]
44. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure.
Biswas S; Miguel RN; Sukla S; Field HJ
J Gen Virol; 2009 Aug; 90(Pt 8):1937-1942. PubMed ID: 19403757
[TBL] [Abstract][Full Text] [Related]
45. The UL8 subunit of the heterotrimeric herpes simplex virus type 1 helicase-primase is required for the unwinding of single strand DNA-binding protein (ICP8)-coated DNA substrates.
Falkenberg M; Bushnell DA; Elias P; Lehman IR
J Biol Chem; 1997 Sep; 272(36):22766-70. PubMed ID: 9278436
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
Katsumata K; Chono K; Kato K; Ohtsu Y; Takakura S; Kontani T; Suzuki H
Antimicrob Agents Chemother; 2013 Mar; 57(3):1339-46. PubMed ID: 23274658
[TBL] [Abstract][Full Text] [Related]
47. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
Zhong L; Hayward GS
J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
[TBL] [Abstract][Full Text] [Related]
48. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.
Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681
[TBL] [Abstract][Full Text] [Related]
49. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
[TBL] [Abstract][Full Text] [Related]
50. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
Wozniak MA; Frost AL; Itzhaki RF
Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
Himaki T; Masui Y; Chono K; Daikoku T; Takemoto M; Haixia B; Okuda T; Suzuki H; Shiraki K
Antiviral Res; 2012 Feb; 93(2):301-304. PubMed ID: 22155691
[TBL] [Abstract][Full Text] [Related]
52. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
[TBL] [Abstract][Full Text] [Related]
53. The UL5 gene of herpes simplex virus type 1: isolation of a lacZ insertion mutant and association of the UL5 gene product with other members of the helicase-primase complex.
Zhu LA; Weller SK
J Virol; 1992 Jan; 66(1):458-68. PubMed ID: 1309255
[TBL] [Abstract][Full Text] [Related]
54. Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor.
Sukla S; Biswas S; Birkmann A; Lischka P; Zimmermann H; Field HJ
J Antimicrob Chemother; 2010 Jul; 65(7):1347-52. PubMed ID: 20453068
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments.
Lukonis CJ; Burkham J; Weller SK
J Virol; 1997 Jun; 71(6):4771-81. PubMed ID: 9151871
[TBL] [Abstract][Full Text] [Related]
56. UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients.
Labrunie T; Ducastelle S; Domenech C; Ader F; Morfin F; Frobert E
Antiviral Res; 2019 Aug; 168():114-120. PubMed ID: 31152759
[TBL] [Abstract][Full Text] [Related]
57. A functional interaction of ICP8, the herpes simplex virus single-stranded DNA-binding protein, and the helicase-primase complex that is dependent on the presence of the UL8 subunit.
Hamatake RK; Bifano M; Hurlburt WW; Tenney DJ
J Gen Virol; 1997 Apr; 78 ( Pt 4)():857-65. PubMed ID: 9129659
[TBL] [Abstract][Full Text] [Related]
58. HSV-1 DNA Replication-Coordinated Regulation by Viral and Cellular Factors.
Packard JE; Dembowski JA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696446
[TBL] [Abstract][Full Text] [Related]
59. One-step column purification of herpes simplex virus 1 helicase-primase subcomplex using C-terminally his-tagged UL5 subunit.
Schreiner U; Theune M; Althof F; Kehm E; Knopf CW
Virus Genes; 2009 Aug; 39(1):19-29. PubMed ID: 19396588
[TBL] [Abstract][Full Text] [Related]
60. The herpes simplex virus type 1 origin-binding protein interacts specifically with the viral UL8 protein.
McLean GW; Abbotts AP; Parry ME; Marsden HS; Stow ND
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2699-706. PubMed ID: 7931156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
